Company / Depreciation & Amortization
FILANA THERAPEUTICS, INC. Depreciation & Amortization History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$15.0K
FY2015
5-year range
$15.0K / $257.0K
FY2011-FY2015
Trend
-87.7%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has declined for 4 consecutive years, from $257,000 in FY2011 to $15,000 in FY2015.
Based on SEC 10-K filings.
$15,000 in FY2015 with a 3-year CAGR of -59.9%.
Improved from $163,000 to $15,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -59.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- FILANA THERAPEUTICS, INC.'s depreciation & amortization has declined for 4 consecutive years.
- 3-year CAGR of -59.9%, indicating a declining trend.
- In FY2015, depreciation & amortization decreased 87.7% year-over-year.
- Peak depreciation & amortization was recorded in FY2011.
Company context
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $15.0K | -87.7% |
| FY2014 | $122.0K | -25.2% |
| FY2013 | $163.0K | -29.7% |
| FY2012 | $232.0K | -9.7% |
| FY2011 | $257.0K | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026